Top Abstract Purchase Related
Home
>
Node
>
Subnode

The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease

Shustval', N.F.

Likars'ka Sprava 9: 73-76

1992

ISSN/ISBN: 1019-5297
PMID: 1481512
Document Number: 388660
The effect of the thymus polypeptide factor-thymidin on the lipid spectrum of the blood, thymic factor content in the blood and clinical course of the disease were studied in 156 patients with exertion stenocardia (II-IV functional class). Results indicate that patients with exertion stenocardia show with advance of the disease a reduction of the blood thymic factor and 85.6% develop hyperlipidemia. Complex treatment with inclusion of thymalin resulted in an increase of the thymic factor, normalization of the lipid metabolism increase of the contractile function of the myocardium and, thus, increases the treatment efficacy.

Document emailed within 1 workday
Secure & encrypted payments

Gorbachev, V.V.; Pristrom, M.S. 1983: The effect of anapriline on the thyroid function and lipid metabolism in ischemic heart disease in elderly patients Terapevticheskii Arkhiv 55(5): 53-56
Ryzhenkov, V.E. 2002: Features of the effect of saturated and unsaturated fatty acids on lipid metabolism, lipoproteins, and development of ischemic heart disease Voprosy Pitaniia 71(3): 40-45
Liusov, V.A.; Gorbachenkov, A.A.; Dudaev, V.A.; Gorin, V.V. 1992: The effect of bee honey and flower pollen on the tolerance for physical loads, on lipid metabolism and on the rheological properties of the blood in patients with ischemic heart disease Kardiologiia 32(7-8): 45-48
Sokolov, E.I.; Perova, N.V. 2004: Hormonal dysregulation of lipid metabolism in pathogenesis of ischemic heart disease Klinicheskaia Meditsina 82(1): 27-31
Polozhentsev, S.D.; Rudnev, D.A. 1988: Status of lipid metabolism in patients with ischemic heart disease and its behavioral risk factor Kardiologiia 28(12): 101-102
Murashko, V.V.; Alekseeva, N.V.; Strutynskiĭ, A.V.; Torkhovskaia, T.I.; Fortinskaia, E.S. 1986: Relation between features of the psychoemotional status and lipid metabolism of patients with ischemic heart disease and arrhythmias Terapevticheskii Arkhiv 58(11): 94-97
Perova, N.V.; Bubnova, M.G.; Aronov, D.M.; Zhidko, N.I.; Olferév, A.M.; Akhmedzhanov, N.M. 1993: Effect of lovastatin on serum lipid and apolipoprotein levels after dietary fat load in patients with ischemic heart disease Kardiologiia 33(4): 8-10
Mikunis, R.I.; Bogach, N.T. 1982: Interrelation of the clinical characteristics of chronic ischemic heart disease and adenine nucleotide metabolism Klinicheskaia Meditsina 60(3): 39-44
Komissarov, V.A.; Tsepa, S.G.; Rakhmanov, V.A. 1988: Effect of Naftusia-Shklo mineral water on liver function and electrolyte metabolism in patients with ischemic heart disease Voenno-Meditsinskii Zhurnal 1988(4): 64
Komarov, F.I.; Ol'binskaia, L.I.; Bragina, G.I. 1979: Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease Terapevticheskii Arkhiv 51(8): 13-17
Lankin, V.Z.; Gerasimova, E.N.; Kasatkina, L.V.; Tikhaze, A.K.; Suchkova, S.N. 1979: Lipid peroxides and atherosclerosis. the enzymatic detoxication of lipid peroxides in the blood in ischemic heart disease due to coronary artery arteriosclerosis Kardiologiia 19(6): 71-76
Samsonov, M.A.; Vasil'ev, A.V.; Pogozheva, A.V.; Pokrovskaia, G.R.; Mal'tsev, G.I.; Biiasheva, I.R.; Orlova, L.A. 1992: The effect of a soy protein isolate and sources of polyunsaturated omega-3 fatty acids in an anti-atherosclerotic diet on the lipid spectrum of blood serum and immunological indicators in patients with ischemic heart disease and hypertension Voprosy Meditsinskoi Khimii 38(5): 47-50
Veryard, C. 2007: American Heart Association - Scientific Sessions 2006. Cell therapies for ischemic tissues and treatments for lipid metabolism disorders IDrugs: the investigational drugs journal 10(1): 17-19
Iskenderov, B.G.; Vakina, T.N. 2005: Effect of pacemaker implantation on clinical course of ischemic heart disease and choice of optimal pacing parameters Kardiologiia 45(2): 7-10
Gavrilova, R.D.; Khanina, S.B.; Simonov, V.V.; Puntus, K.K.; Zybin, O.K. 1987: Blood lipid levels in various forms of ischemic heart disease Kardiologiia 27(10): 51-55
Dudaev, V.A.; Diukov, I.V.; Borodkin, V.V. 1988: Effect of physical training on the clinical course and the status of blood coagulation hemostasis in patients with ischemic heart disease Kardiologiia 28(11): 22-26
Gaglio, M.; Caruso, G.; Milone, A.; Trovato, G.M.; Vancheri, F.S. 1984: Blood lipid patterns in ischemic heart disease and cerebrovascular diseases Cardiologia 29(3-4): 203-210
Klantsa, N.A.; Kushnir, V.S. 1976: Electrolyte metabolism in ischemic heart disease Vrachebnoe Delo 9: 27-30
Novgorodtseva, T.P.; Endakova, E.A.; Ivanov, E.M. 1993: The lipid component of the erythrocytes in young men in the symptom-free stages of ischemic heart disease Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 3: 41-43
Kratnov, A.E. 2012: The intracellular metabolism of neutrophils under different forms of ischemic heart disease Klinicheskaia Laboratornaia Diagnostika 12: 10-12